Tempol and L-NAME help prevent the decrease in F_max. by Travis L. Dutka (321984)

Cellular uptake of [¹⁴C]docosahexaenoic acid (DHA) by RBECs transfected with MFSD2A siRNA. by Takuro Iwao (14636741)

Activation of AKT, decrease in FOXO and activation of glycolytic genes in CERT heterozygous mice. by Niraj K. Nirala (424266)

“…(D). A simple graphical model depicting metabolic reprogramming in <i>dcerk¹</i> due to increased AKT activation and decreased FOXO to maintain energy balance. …”

Apicoplast inhibitors decrease global parasite prenylation in the second IDC after treatment. by Kit Kennedy (4915510)

Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial - Fig 4 by José Tarcisio G. Carvalho (4217248)

Subjects:

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on oxidative burst capacity of neutrophils after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

Influence of ghrelin treatment (0.5 μg/g BW, twice a day, intraperitoneal (ip.)) on peritoneal cellular immune response after cecal ligation and puncture (CLP)-induced sepsis. by Daniel Siegl (717509)

Terpenoids decrease single-channel activity of L-AChRs elicited by ACh. by Guillermina Hernando (553795)

Cell-penetrating 15mer peptides decrease the proliferation and viability of cancer cells. by Pavan Kumar Puvvula (10495853)

The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

“…<p>(A) The GluN2B-C456Y mutation strongly decreases diheteromeric GluN1/GluN2B NMDAR currents in <i>Xenopus</i> oocytes. …”

HoxA9-ER directly represses <i>Cebpa</i> gene expression in myeloid cells. by Lei Peng (260321)

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

Quantification of <i>ATP5B</i> mRNA and β-F1-ATPase protein expression shows decreased protein translation in obesity. by Lee Tran (2106961)

Conditioning with glucose and sodium ions decreases chemotaxis to sodium ions and glucose, respectively. by Masahiro Tomioka (430683)

ERG amplitude and peak latency gradually decreased after the continuous dark exposure. by Dake Li (2940168)

eNOS^-/- decreased synaptic protein expression in the ischemic brain. by Xu Cui (261214)

LC3-II immunohistochemistry in PCs was decreased in ET cases vs. controls. by Sheng-Han Kuo (292031)

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Frequency of septicemic plague in the absence of primary pneumonia increases with decreasing dosing volume. by Rachel M. Olson (6729983)

3D reconstruction from confocal planes (thresholded for Nemp1 intensity to emphasize Nemp1 aggregates, top panels) of erythroblasts undergoing a small nuclear envelope opening. by Didier Hodzic (132944)